World's Best Scientists 2026 revealed!
Haemophilia
H-index 24

Haemophilia

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 965 51 193 24

Additional Metrics

Number of Best Scientists*: 111
Documents by Best Scientists*: 254
Top 100 Ranked Scientists*: 3
SCIMAGO H-index: 107
SCIMAGO SJR: 0.926
Impact Factor: 3

Overview

Top Research Topics at Haemophilia?

The foci of Haemophilia are Haemophilia, Haemophilia A, Surgery, Internal medicine and Pediatrics. The journal facilitates discussions in Haemophilia B as part of the larger field of Haemophilia, however, it also tackles fields such as In patient. Haemophilia focused on Haemophilia B research but expanded to cover Factor IX.

In Haemophilia, Adverse effect, Immune tolerance and Immunology are investigated in conjunction with one another to address concerns in Haemophilia A research. Most of the Immunology studies addressed also intersect with Coagulation. The journal links adjacent topics like Surgery with Anesthesia.

The journal explores issues in Internal medicine which can be linked to other research areas like Gastroenterology and Endocrinology. Pediatrics research featured in it incorporates concerns from various other topics such as MEDLINE, Young adult, Quality of life, Disease and Clotting factor.

  • Haemophilia (52.77%)
  • Haemophilia A (25.08%)
  • Surgery (22.90%)

What are the most cited papers published in the journal?

  • Guidelines for the management of hemophilia. (1246 citations)
  • von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). (714 citations)
  • The epidemiology of inhibitors in haemophilia A: a systematic review. (496 citations)

Research areas of the most cited articles at Haemophilia:

Haemophilia, Haemophilia A, Surgery, Pediatrics and Internal medicine are the main subjects of interest in the journal papers. Haemophilia B is a major topic of Haemophilia research in the journal articles. Aside from discussions in Haemophilia A, the most cited articles also deal with the subject of Immunology which intersects with Coagulation disciplines.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Surgery
  • Disease

The previous edition focused in particular on these issues:

The journal generally zeroes in on subjects such as Haemophilia, Haemophilia A, Internal medicine, Pediatrics and Emicizumab. The Haemophilia B studies presented in Haemophilia fall under the field of Haemophilia, but it also has connections to other fields such as In patient. Some problems in Haemophilia A that were presented in the journal overlapped with concepts under Pharmacokinetics, Quality of life, Physical therapy and Dosing.

The research on Internal medicine featured in Haemophilia combines topics in other fields like Gastroenterology and Oncology. While Pediatrics is the focus of it, it also provided insights into the studies of Von Willebrand disease and MEDLINE. While Haemophilia focused on Family medicine, it was also able to explore topics like Coronavirus disease 2019 (COVID-19), Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and 2019-20 coronavirus outbreak.

The most cited articles from the last journal are:

  • Uncertainty in an era of transformative therapy for haemophilia: Addressing the unknowns. (9 citations)
  • Patient perspectives regarding gene therapy in haemophilia: Interviews from the PAVING study (7 citations)
  • COVID-19 and telemedicine in haemophilia in a patient with severe haemophilia A and orthopaedic surgery. (7 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Haemophilia (based on the number of publications) are:

  • Erik Berntorp (146 papers) published 7 papers at the last edition, 5 more than at the previous edition,
  • Krista Fischer (143 papers) published 11 papers at the last edition, 4 more than at the previous edition,
  • Johannes Oldenburg (111 papers) published 8 papers at the last edition, 2 more than at the previous edition,
  • E. C. Rodriguez-Merchan (78 papers) published 1 paper at the last edition the same number as at the previous edition,
  • Amy D. Shapiro (77 papers) published 6 papers at the last edition, 3 more than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Haemophilia (based on the number of publications) are:

  • Boston Children's Hospital (323 papers) published 27 papers at the last edition, 17 more than at the previous edition,
  • Utrecht University (177 papers) published 15 papers at the last edition, 6 more than at the previous edition,
  • Royal Free Hospital (176 papers) published 7 papers at the last edition, 2 less than at the previous edition,
  • University of Milan (165 papers) published 5 papers at the last edition, 3 more than at the previous edition,
  • University of Toronto (142 papers) published 5 papers at the last edition the same number as at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 14.11% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 33.21% were posted by at least one author from the top 10 institutions publishing in the journal. Another 7.66% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 13.14% of all publications and 45.99% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Opportunities for Further Study and Collaboration

As we delve into the depth of Haemophilia related research, it is essential to identify the intersections with other medical disciplines. Notably, there are opportunities for collaboration with professionals outside of this specialization to broaden our understanding and create new innovative solutions to intricate problems. Combining research themes can lead to meaningful strides in curing and managing diseases.

For instance, the integration of study in Haemophilia with knowledge in modern nursing practices can enhance Patient-Centered Care and Nursing Diagnosis. Nurses, especially those specializing in online nursing programs, play a crucial role in managing routine care and educating patients about disease management. Engaging with nursing research and academia can enhance the multidisciplinary approaches necessary to improve Haemophilia patient outcomes.

While not explicitly covered in this journal, we encourage interested researchers to look into the field of nursing and consider the advantages of interdisciplinary research collaboration. A starting point can be exploring {anchor}online nursing programs in Oregon, which are known for their collaborative opportunities with medical research studies.

By crossing the borders of our specializations, researchers can break new grounds to advance the scientific knowledge of Haemophilia and related health scenarios.

Top Publications

  • WFH Guidelines for the Management of Hemophilia, 3rd edition

    Alok Srivastava;Elena Santagostino;Alison Dougall;Steve Kitchen

    (2020)
    1329 Citations
  • Persistence of haemostatic response following gene therapy with valoctocogene roxaparvovec in severe haemophilia A.

    K John Pasi;Michael Laffan;Savita Rangarajan;Tara M Robinson

    (2021)
    80 Citations
  • Achieving the unimaginable : Health equity in haemophilia

    Mark W. Skinner;Diane Nugent;Pam Wilton;Brian O’Mahony

    (2020)
    76 Citations
  • Recombinant factor VIII Fc fusion protein for the treatment of severe haemophilia A: Final results from the ASPIRE extension study

    Beatrice Nolan;Johnny N. Mahlangu;Ingrid Pabinger;Guy Young;Guy Young

    (2020)
    58 Citations
  • European principles of care for women and girls with inherited bleeding disorders

    Karin van Galen;Michelle Lavin;Naja Skouw-Rasmussen;Kathelijn Fischer

    (2021)
    40 Citations
  • Delivery of AAV‐based gene therapy through haemophilia centres—A need for re‐evaluation of infrastructure and comprehensive care: A Joint publication of EAHAD and EHC

    Wolfgang Miesbach;Pratima Chowdary;Michiel Coppens;Daniel P. Hart

    (2021)
    40 Citations
  • World Federation of Hemophilia Gene Therapy Registry.

    Barbara A Konkle;Donna Coffin;Glenn F Pierce;Cary Clark

    (2020)
    36 Citations
  • Long-term safety and sustained efficacy for up to 5 years of treatment with recombinant factor IX Fc fusion protein in subjects with haemophilia B: Results from the B-YOND extension study.

    K. John Pasi;Kathelijn Fischer;Margaret Ragni;Roshni Kulkarni

    (2020)
    36 Citations
  • The effect of emicizumab prophylaxis on long-term, self-reported physical health in persons with haemophilia A without factor VIII inhibitors in the HAVEN 3 and HAVEN 4 studies.

    Mark W Skinner;Claude Négrier;Ido Paz-Priel;Sammy Chebon

    (2021)
    31 Citations
  • An international survey to inform priorities for new guidelines on von Willebrand disease.

    Kalot Ma;Al-Khatib M;Connell Nt

    (2020)
    31 Citations

Related Online Degrees & Career Pathways

For those interested in expanding their medical careers beyond traditional practice, several online degree options and certifications offer flexible and affordable pathways. An online doctorate in nursing is a valuable choice for nurses seeking advanced clinical or leadership roles without pausing their professional work. These programs combine rigorous academics with the convenience of remote learning.

In addition, the healthcare industry offers robust opportunities in medical administration. Students can explore medical billing and coding schools online, which prepare them for essential back-office roles that keep healthcare systems running smoothly and efficiently.

Graduates with a biology background also have diverse career options. According to highest paying jobs with a biology degree, fields like biomedical research, pharmaceuticals, and healthcare consulting reward specialized knowledge with competitive salaries.

For those pursuing medical coding certification, understanding the differences between the ccs vs cpc certification can help determine the best credential based on career goals, costs, and salary expectations. Each certification opens unique opportunities within the medical billing and coding landscape.

Best Scientists Contributing to This Journal

Recently Published Articles